Life Sciences Tools and Services

AbbVie (ABBV) acquires Cerevel, enhancing its drug portfolio and opening new growth avenues in neuroscience for investors in ABBV stock.

Are you looking for the best TSXV stocks the Toronto Stock Exchange has to offer? Here’s our guide on how to find top stocks, emerging firms, and...

Bayer's legal and pharmaceutical setbacks are something investors should pay attention to. These issues could impact BAYRY stock value and guide...

Safe Supply (SPLY) presents a visionary bet on legal cocaine. Explore retail investment potential in drug policy reform.

Shares of Veeva Systems Inc (NYSE: VEEV) are markedly lower on Friday on the back of earnings disappointment. But with few competitors and a...

Are biopharma stocks the missing secret ingredient for your portfolio? Read on to find out why investing in biopharma could leave you with sizeable...

Achieve Life Sciences (NASDAQ: ACHV) is developing a treatment to help smokers quit cigarettes and e-cigarettes.

With weed legalization legislation introduced to the Senate earlier this summer, savvy investors might be keen to work out the best cannabis penny...

Shroom stocks, otherwise known as psychedelic stocks, present an early-stage investment opportunity that could result in mainstream health treatments.

Applied DNA Sciences (NASDAQ: APDN) has seen its share price more than double after big news for its clinical laboratory subsidiary. Is APDN stock...

With major backing and a promising lead product candidate, Legend Biotech stock looks like an exciting investment opportunity. But is this life...

The Danaher (NASDAQ: DHR) share price is rising as Q2 results please investors. Does this mean Danaher stock is a buy?

Investment in Life Sciences has exploded in recent years. But what is Life Sciences? Read on to discover the nature-based opportunities in this field.

Open Orphan is making headlines as the Covid-19 pandemic highlights the importance of its work in the infectious diseases space.

A new wave of research into malaria treatments has kicked off over the last 18 months. Which is great news for clinical research organisation Open...